QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
QQQ   359.61 (+0.47%)
AAPL   176.08 (+0.74%)
MSFT   317.54 (+0.17%)
META   300.83 (+0.59%)
GOOGL   131.11 (+0.66%)
AMZN   131.27 (+1.67%)
TSLA   246.99 (+0.86%)
NVDA   422.22 (+1.47%)
NIO   8.34 (-2.23%)
BABA   87.20 (-1.25%)
AMD   97.38 (+1.23%)
T   15.06 (-0.40%)
F   12.59 (+1.29%)
MU   68.58 (-0.44%)
CGC   0.94 (+11.86%)
GE   111.70 (+0.40%)
DIS   81.01 (-0.30%)
AMC   8.15 (+6.82%)
PFE   32.98 (+0.89%)
PYPL   58.86 (+1.69%)
NFLX   384.80 (+1.31%)
NASDAQ:EXPO

Exponent (EXPO) Stock Forecast, Price & News

$86.33
+0.66 (+0.77%)
(As of 09/25/2023 ET)
Compare
Today's Range
$85.08
$86.46
50-Day Range
$85.67
$96.48
52-Week Range
$85.08
$112.75
Volume
179,162 shs
Average Volume
290,557 shs
Market Capitalization
$4.39 billion
P/E Ratio
43.82
Dividend Yield
1.20%
Price Target
$104.50

Exponent MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
21.0% Upside
$104.50 Price Target
Short Interest
Healthy
2.11% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
-0.03mentions of Exponent in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$176,270 Sold Last Quarter
Proj. Earnings Growth
9.27%
From $2.05 to $2.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.48 out of 5 stars

Business Services Sector

94th out of 310 stocks

Management Consulting Services Industry

7th out of 15 stocks


EXPO stock logo

About Exponent (NASDAQ:EXPO) Stock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

EXPO Price History

EXPO Stock News Headlines

How to Buy OpenAI Stock: A Guide (EXPO)
Can you buy OpenAI stock? Open AI is not yet publicly traded, but there are other ways you can get in on this branch of artificial intelligence. Learn more.
7 Best Fintech ETFs to Buy Now (EXPO)
Fintech seizes the spotlight regularly, so why not connect with ETFs for an investment opportunity? Learn more about investing in fintech ETFs.
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
‘Our art forms are like rivers’
Exponent, Inc. (NASDAQ:EXPO) Goes Ex-Dividend Soon
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Here’s Why Exponent (EXPO) Declined in Q2
Q2 2023 Exponent Inc Earnings Call
Exponent Declares Quarterly Dividend for Q3 2023
EXPO - Exponent, Inc.
Exponent: High Quality At A High Price
Exponent Inc.
See More Headlines
Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Company Calendar

Last Earnings
7/27/2023
Ex-Dividend for 9/22 Dividend
9/07/2023
Dividend Payable
9/22/2023
Today
9/25/2023
Next Earnings (Estimated)
10/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
Research & Consulting Services
Current Symbol
NASDAQ:EXPO
CUSIP
30214U10
Employees
1,313
Year Founded
1967

Price Target and Rating

Average Stock Price Forecast
$104.50
High Stock Price Forecast
$110.00
Low Stock Price Forecast
$99.00
Forecasted Upside/Downside
+21.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$102.33 million
Pretax Margin
25.38%

Debt

Sales & Book Value

Annual Sales
$513.29 million
Cash Flow
$2.18 per share
Book Value
$6.33 per share

Miscellaneous

Free Float
49,730,000
Market Cap
$4.39 billion
Optionable
Optionable
Beta
0.61

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Catherine Ford Corrigan P.E. (Age 54)
    Ph.D., Pres, CEO & Director
    Comp: $1.79M
  • Mr. Richard L. Schlenker Jr.Mr. Richard L. Schlenker Jr. (Age 57)
    Exec. VP, CFO & Corp. Sec.
    Comp: $1.14M
  • Dr. Bernard Ross P.E.
    Ph.D., Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi P.E. (Age 76)
    Ph.D., CTO & Principal Engineer
  • Ms. Sally B. ShepardMs. Sally B. Shepard (Age 62)
    Chief HR Officer
  • Dr. Eric Guyer P.E.
    Ph.D., Group VP for US Offices & Principal Engineer
  • Mr. Eric R. Anderson
    VP & Corp. Controller
  • Joseph RakowJoseph Rakow
    Group VP
  • Mr. Richard Fioravanti
    Principal Consultant













EXPO Stock - Frequently Asked Questions

Should I buy or sell Exponent stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" EXPO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EXPO, but not buy additional shares or sell existing shares.
View EXPO analyst ratings
or view top-rated stocks.

What is Exponent's stock price forecast for 2023?

3 brokerages have issued 12 month price objectives for Exponent's shares. Their EXPO share price forecasts range from $99.00 to $110.00. On average, they expect the company's share price to reach $104.50 in the next year. This suggests a possible upside of 21.0% from the stock's current price.
View analysts price targets for EXPO
or view top-rated stocks among Wall Street analysts.

How have EXPO shares performed in 2023?

Exponent's stock was trading at $99.09 at the start of the year. Since then, EXPO stock has decreased by 12.9% and is now trading at $86.33.
View the best growth stocks for 2023 here
.

Are investors shorting Exponent?

Exponent saw a decrease in short interest in August. As of August 31st, there was short interest totaling 1,060,000 shares, a decrease of 10.2% from the August 15th total of 1,180,000 shares. Based on an average daily trading volume, of 224,100 shares, the days-to-cover ratio is presently 4.7 days. Approximately 2.1% of the company's shares are sold short.
View Exponent's Short Interest
.

When is Exponent's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023.
View our EXPO earnings forecast
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings results on Thursday, July, 27th. The business services provider reported $0.50 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.51 by $0.01. The business services provider had revenue of $129.65 million for the quarter, compared to analyst estimates of $130.40 million. Exponent had a trailing twelve-month return on equity of 30.41% and a net margin of 19.03%. The firm's revenue was up 9.7% on a year-over-year basis. During the same period last year, the business earned $0.49 EPS.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent announced a quarterly dividend on Tuesday, July 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.26 per share on Friday, September 22nd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for EXPO
.

Is Exponent a good dividend stock?

Exponent (NASDAQ:EXPO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.21%. The company has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 52.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 46.43% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.

When did Exponent's stock split?

Exponent shares split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were issued to shareholders after the market closes on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?

15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.83%), Kayne Anderson Rudnick Investment Management LLC (8.41%), Conestoga Capital Advisors LLC (4.75%), State Street Corp (3.33%), Geneva Capital Management LLC (2.78%) and Geode Capital Management LLC (2.32%). Insiders that own company stock include Bradley A James, Carol Lindstrom, George H Brown, Harri Kytomaa, John Pye, Joseph Rakow, Maureen T F Reitman, Paul R Johnston, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends
.

How do I buy shares of Exponent?

Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $86.33.

How much money does Exponent make?

Exponent (NASDAQ:EXPO) has a market capitalization of $4.39 billion and generates $513.29 million in revenue each year. The business services provider earns $102.33 million in net income (profit) each year or $1.97 on an earnings per share basis.

How many employees does Exponent have?

The company employs 1,313 workers across the globe.

Does Exponent have any subsidiaries?
The following companies are subsidiares of Exponent: Dennis Publishing.
Read More
How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.

This page (NASDAQ:EXPO) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -